← Back to front page
Europe · Wires & real time · Reuters

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Published by Reuters · United Kingdom 9 h ago

Novo Nordisk's ‌Wegovy weight-loss pill beat third-quarter sales forecasts and the drug maker lifted its full-year outlook again on Wednesday, boosting efforts to regain lost…

Read the full article on Reuters Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Armenian security officers detain opposition leader Karapetyan

 Anadolu Agency

US trade deficit narrows to $105B in September as exports rise

 Reuters US Markets

Prediction markets get Democratic win right, with a few surprises

 Reuters Technology

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026

 Reuters Europe Markets

Revolut's rise to become Europe's $115 billion big bank rival

 Reuters Breakingviews

BMW tune-up fixes today’s problem not tomorrow’s